Home LiteratureArticle Details
PMID: 3922531 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.

British medical journal (Clinical research ed.) ·Vol. 290 ·No. 6480 ·1985-05-18 ·Pages 1453-6

Nilsson IM, Ljungnér H, Tengborn L

Abstract

Fibrinolytic components after venous occlusion and concentrations of tissue plasminogen activator inhibitor were studied in 100 consecutive patients with confirmed recurrent deep vein thrombosis or pulmonary embolism. After 20 minutes of venous occlusion the fibrinolytic response was decreased in 33 patients, as measured both amidolytically with S-2251 and on fibrin plates. Two different mechanisms responsible for the poor fibrinolytic response could be distinguished. Twenty two of the patients in whom the response was poor released normal amounts of tissue plasminogen activator antigen, as assayed by immunoradiometric assay, but had appreciably increased concentrations of tissue plasminogen activator inhibitor. The 11 other patients in whom the response was poor had both low tissue plasminogen activator activities and low tissue plasminogen activator antigen concentrations but normal concentrations of tissue plasminogen activator inhibitor. The results show not only that defective synthesis or release of tissue plasminogen activator may be important in the pathogenesis of venous thrombosis but also that a large group of patients with thrombosis have an increased concentration of the inhibitor to tissue plasminogen activator.

MeSH Terms
Adolescent Adult Aged Blood Coagulation Tests Female Fibrinolysis Glycoproteins/blood Humans Male Middle Aged Plasminogen Activators/antagonists & inhibitors,blood Plasminogen Inactivators Thrombophlebitis/enzymology,etiology Vasoconstriction
Chemicals
Glycoproteins Plasminogen Inactivators Plasminogen Activators
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Nilsson I M
Ljungnér H
Tengborn L
References (30)
30 references, click to expand
  1. Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis.
    Acta Chir Scand. 1972;138(4):313-9 PMID: 5040598
  2. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system.
    Acta Med Scand. 1961 Mar;169:323-37 PMID: 13729173
  3. "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms.
    Acta Chir Scand. 1972;138(5):429-36 PMID: 5055974
  4. Two genetic variants of von Willebrand's disease.
    N Engl J Med. 1973 Mar 22;288(12):595-8 PMID: 4539979
  5. Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease.
    Circ Res. 1973 Jun;32(6):752-8 PMID: 4715196
  6. Heparin cofactor activity measured with an amidolytic method.
    Thromb Res. 1975 Apr;6(4):287-94 PMID: 49087
  7. Coagulation, fibrinolysis and venous thrombosis.
    Triangle. 1977;16(1):19-27 PMID: 331606
  8. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.
    Proc Natl Acad Sci U S A. 1977 Sep;74(9):3903-7 PMID: 143664
  9. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.
    Scand J Clin Lab Invest. 1977 Sep;37(5):403-9 PMID: 73215
  10. A family with thromboembolic disease associated with deficient fibrinolytic activity in vessel wall.
    Acta Med Scand. 1978;203(6):477-80 PMID: 665314
  11. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.
    Biochim Biophys Acta. 1978 Nov 15;544(1):128-37 PMID: 152655
  12. Comparative studies of the fibrinolytic activity of cultured vascular cells.
    Thromb Res. 1979;15(5-6):869-78 PMID: 494183
  13. Relationship between tissue plasminogen activator and the activators in blood and vascular wall.
    Thromb Res. 1980 Jun 15;18(6):815-30 PMID: 7191151
  14. Deep venous thrombosis of the arm: a study of coagulation and fibrinolysis.
    Br Med J (Clin Res Ed). 1981 Jul 25;283(6286):265-7 PMID: 6788281
  15. Studies of the blood plasminogen activator induced by 1-desamino-8-D-arginine vasopressin with observations in von Willebrand's disease.
    Proc Soc Exp Biol Med. 1982 Jun;170(2):126-32 PMID: 6979752
  16. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Nouv Rev Fr Hematol. 1982;24(3):205-9 PMID: 7133990
  17. Plasminogen activator activity of superficial veins in acute deep venous thrombosis.
    Vasa. 1982;11(3):174-7 PMID: 6890278
  18. A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis.
    Scand J Haematol. 1982 Sep;29(3):217-23 PMID: 6890710
  19. Clinical relevance of antithrombin III.
    Semin Thromb Hemost. 1982 Oct;8(4):276-87 PMID: 6758119
  20. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.
    Nature. 1983 Jan 20;301(5897):214-21 PMID: 6337343
  21. Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells.
    Biochem Biophys Res Commun. 1983 Jan 27;110(2):392-8 PMID: 6404257
  22. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
    Proc Natl Acad Sci U S A. 1983 May;80(10):2956-60 PMID: 6574465
  23. Immunological characterisation of plasminogen activators in the human vessel wall.
    J Clin Pathol. 1983 Sep;36(9):1046-9 PMID: 6684128
  24. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.
    Proc Natl Acad Sci U S A. 1983 Nov;80(22):6804-8 PMID: 6580616
  25. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions.
    Thromb Res. 1984 Mar 1;33(5):523-30 PMID: 6426082
  26. Clinical studies of protein C.
    Semin Thromb Hemost. 1984 Apr;10(2):162-6 PMID: 6377499
  27. Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor.
    Br J Haematol. 1984 Jul;57(3):407-12 PMID: 6430331
  28. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
    Thromb Haemost. 1984 Jul 29;51(3):392-5 PMID: 6437006
  29. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Thromb Haemost. 1984 Jul 29;51(3):396-7 PMID: 6437007
  30. On release and synthesis of fibrinolytic activators in human organ culture.
    Rev Eur Etud Clin Biol. 1972 Mar;17(3):261-7 PMID: 4262312
Article Info
Journal
British medical journal (Clinical research ed.)
Abbr.
Br Med J (Clin Res Ed)
ISSN
0267-0623
Published
1985-05-18
Pages
1453-6
Language
English
Region
England
NLM ID
8302911
PMCID
PMC1415704
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]